Author(s):
Mule Asmita, Kote Rupali Balasaheb, Jadhav Ravindra S, Khemnar Ashwini, Jinat Maniyar, Khetmalis Aditya, Monika Magar, Nikita Borse
Email(s):
rupalikote236@gmail.com
DOI:
10.52711/2321-5836.2026.00014 
Address:
Mule Asmita*, Kote Rupali Balasaheb, Jadhav Ravindra S, Khemnar Ashwini, Jinat Maniyar, Khetmalis Aditya, Monika Magar, Nikita Borse
Department of Pharmaceutics, Pravara Rural Education Society's Institute of Pharmacy, Loni.
*Corresponding Author
Published In:
Volume - 18,
Issue - 1,
Year - 2026
ABSTRACT:
Ocular drug delivery remains one of the major challenges in pharmaceutical research due to the complex anatomy and physiology of the eye. The eye, being a delicate and highly protected organ responsible for vision, presents various barriers that hinder effective drug absorption. The purpose of ocular drug delivery systems is to achieve therapeutic concentrations of drugs at the target site while minimizing systemic exposure and side effects. This review discusses the anatomy of the eye relevant to drug delivery, various routes of ocular administration, physiological barriers, dosage forms, and recent advancements in ocular delivery technologies. The advantages, limitations, and marketed products for different ocular dosage forms are also reviewed. The review further highlights recent innovations such as in-situ gels, nanoparticles, and implants, which offer controlled and sustained release profiles for improved therapeutic efficacy.
Cite this article:
Mule Asmita, Kote Rupali Balasaheb, Jadhav Ravindra S, Khemnar Ashwini, Jinat Maniyar, Khetmalis Aditya, Monika Magar, Nikita Borse. A Review on Ocular Drug Delivery System. Research Journal of Pharmacology and Pharmacodynamics. 2026;18(1):107-0. doi: 10.52711/2321-5836.2026.00014
Cite(Electronic):
Mule Asmita, Kote Rupali Balasaheb, Jadhav Ravindra S, Khemnar Ashwini, Jinat Maniyar, Khetmalis Aditya, Monika Magar, Nikita Borse. A Review on Ocular Drug Delivery System. Research Journal of Pharmacology and Pharmacodynamics. 2026;18(1):107-0. doi: 10.52711/2321-5836.2026.00014 Available on: https://www.rjppd.org/AbstractView.aspx?PID=2026-18-1-14
REFERENCES:
1. Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: An overview. World J Pharmacol. 2013; 2(2): 47–64.
2. Singh M, Tyagi S, Verma R. Recent advances in ocular drug delivery systems. Res J Pharmacodyn Pharmacol. 2020; 12(1):33–42.
3. Nanjwade BK, et al. Development and evaluation of in-situ gelling systems for ocular drug delivery. Res J Pharmacodyn Pharmacol. 2019; 11(3): 127–134.
4. Kumar S, et al. Nanotechnology in ophthalmic drug delivery. Res J Pharmacodyn Pharmacol. 2021; 13(2): 55–63.
5. Jain R, et al. Ocular barriers and strategies to overcome them. Int J Pharm Sci Res. 2018; 9(4): 1345–1353.
6. Shinde GS, Rao PS, Jadhav RS, Kolhe P, Athare D. A review on chromatography and advancement in paper chromatography technique. Asian Journal of Pharmaceutical Analysis. 2021; 11(1): 45-8
7. Chauhan A, Radke CJ. Controlled release of drugs from ophthalmic delivery systems. Adv Drug Deliv Rev. 2012; 64(6): 666–685.
8. Shinde, G. S., Jadhav, R., Vikhe, D., and Kote, R. B. Development and evaluation of herbal fast disintegrating tablet of Achyranthes aspera linn root extract. Asian Journal of Pharmacy and Technology, 2024: 14(2): 119-122.
9. Shinde, G. S, Jadhav R S, Tambe V B, Kote R B .RP-HPLC Method Development and Validation of Lamivudine, Zidovudine and Nevirapine in Bulk and Dosage form using UV Detector." Research Journal of Pharmacy and Technology. 2024; 17(10): 5011-5015
10. Suresh PK, Barsa G, Sah AK, Daharwal SJ. Ocular implants as drug delivery device in ophthalmic therapeutics: An overview. Res J Pharm Technol. 2014; 7(6): 687–693.
11. Shinde GS, Jadhav RS, Kote RB, Kadam AJ, Bankar AA. Bioanalytical Method Development and Validation of UV Spectrophotometric Method for Estimation of Metformin Hydrochloride in Urine Sample. Asian J Res Chem. 2024; 17(2): 93–6. doi: 10.52711/0974-4150.2024.00019
12. Karthikeyan D, Vijaikumar S, Pandey VP, Nandha Kumar J, Sengottuvelu S, Shivakumar T. Preparation and evaluation of ocular inserts for controlled delivery of Ciprofloxacin hydrochloride. Res J Pharm Technol. 2008; 1(1): 37–41.
13. Nautiyal D, Singh V, Ali S. Formulation and evaluation of sustained release of Ofloxacin ocular inserts. Res J Pharm Technol. 2012; 5(12): 1533–1538.
14. Karthikeyan D, Sonkar S, Pandey VP, Nandha Kumar J, Sengottuvelu S, Bhowmick M, Shivakumar T. Development and characterization of modified ocular inserts with improved ocular compatibility. Res J Pharm Technol. 2008; 1(2): 93–99.
15. Godge RK, Shinde GS, Joshi S. Simultaneous Estimation and Validation of Dapagliflozin and Saxagliptin in Bulk Drug and Dosage Form by RP-HPLC. Research Journal of Science and Technology. 2019; 11(1):59-63
16. Gupta SK, Singhvi IL. In-situ gelling system and other possible innovative approach for ocular disease: A review. Res J Pharm Technol. 2011; 4(6): 825–829.
17. Shinde V, Amsa P, Tamizharasi S, Karthikeyan D, Shivakumar T, Kale A. Formulation and characterization of Eudragit RS 100 nanosuspension for ocular delivery of indomethacin. Res J Pharm Technol. 2010;3(3):779–784.
18. Nayak S, Jadhav M, Bhaskar V. Recent advances in ocular drug delivery system. Res J Pharm Technol. 2016; 9(7): 789–795.
19. Shinde G, Godage RK, Jadhav RS, Manoj B, Aniket B. A Review on Advances in UV Spectroscopy. Research Journal of Science and Technology. 2020; 12(1): 47-51.
20. Nair RV, Nair SC, Anoop KR. Current trends in ocular drug systems and its applications. Res J Pharm Technol. 2015; 8(5): 589–595.
21. Pawar P, Yadav A, Gharge V. Ocular drug delivery and novel formulation: A review. Asian J Pharm Technol. 2018; 8(4): 218–224